| | | | | Product | Package Size | EFP | CP | SB | DC | Composition | Registr. Holder | Category | | | | |
---|
|
| | IP | CI | | Divigel 0,5 g | | PR | PR | k.A. | | Gel: Estradiolum | Orion Pharma AG | B | FB | | G |  |
| | IP | CI | | Divigel 1,0 g | | PR | PR | k.A. | | Gel: Estradiolum 1 mg | Orion Pharma AG | B | FB | | G |  |
| | IP | CI | | Lenzetto | | PR | PR | k.A. | | transdermales Spray: Estradiolum 1.53 mg | Gedeon Richter (Schweiz) AG | B | FB | | G |  |
| | IP | CI | | Lenzetto | 3 | PR | PR | k.A. | | transdermales Spray: Estradiolum 1.53 mg | Gedeon Richter (Schweiz) AG | B | FB | | G |  |
| | IP | CI | | Vagirux 10 μg | 18 | 7.82 | 17.75 | 10 % | | Vaginal tablets: Estradiolum | Gedeon Richter (Schweiz) AG | B / SL / SG | FB | | G |  |
| | IP | CI | | Estradot 25 | 8 plaster(s) | 6.74 | 16.55 | 10 % | | Transdermal patch: Estradiolum 390 µg | Sandoz Pharmaceuticals AG | ● B / SL | FB | | G |  |
| | IP | CI | | Estradot 25 | 24 plaster(s) | 17.41 | 35.35 | 10 % | | Transdermal patch: Estradiolum 390 µg | Sandoz Pharmaceuticals AG | B / SL | FB | | G |  |
| | IP | CI | | Estradot 37.5 | 8 plaster(s) | 6.74 | 16.55 | 10 % | | Transdermal patch: Estradiolum 585 µg | Sandoz Pharmaceuticals AG | ● B / SL | FB | | G |  |
| | IP | CI | | Estradot 37.5 | 24 plaster(s) | 17.41 | 35.35 | 10 % | | Transdermal patch: Estradiolum 585 µg | Sandoz Pharmaceuticals AG | B / SL | FB | | G |  |
| | IP | CI | | Estradot 50 | 8 plaster(s) | 6.74 | 16.55 | 10 % | | Transdermal patch: Estradiolum 780 µg | Sandoz Pharmaceuticals AG | ● B / SL | FB | | G |  |
| | IP | CI | | Estradot 50 | 24 plaster(s) | 17.41 | 35.35 | 10 % | | Transdermal patch: Estradiolum 780 µg | Sandoz Pharmaceuticals AG | ● B / SL | FB | | G |  |
| | IP | CI | | Estradot 75 | 8 plaster(s) | 6.74 | 16.55 | 10 % | | Transdermal patch: Estradiolum 1.17 mg | Sandoz Pharmaceuticals AG | B / SL | FB | | G |  |
| | IP | CI | | Estradot 75 | 24 plaster(s) | 17.41 | 35.35 | 10 % | | Transdermal patch: Estradiolum 1.17 mg | Sandoz Pharmaceuticals AG | B / SL | FB | | G |  |
| | IP | CI | | Estradot 100 | 8 plaster(s) | 6.74 | 16.55 | 10 % | | Transdermal patch: Estradiolum 1.56 mg | Sandoz Pharmaceuticals AG | B / SL | FB | | G |  |
| | IP | CI | | Estradot 100 | 24 plaster(s) | 17.41 | 35.35 | 10 % | | Transdermal patch: Estradiolum 1.56 mg | Sandoz Pharmaceuticals AG | B / SL | FB | | G |  |
| | IP | CI | | Divigel 0,5 g | 28 x 0.5 g | 4.25 | 13.85 | 10 % | | Gel: Estradiolum | Orion Pharma AG | B / SL | FB | | G |  |
| | IP | CI | | Divigel 0,5 g | 91 x 0.5 g | 11.85 | 29.30 | 10 % | | Gel: Estradiolum | Orion Pharma AG | B / SL | FB | | G |  |
| | IP | CI | | Divigel 1,0 g | 28 x 1 g | 6.01 | 15.75 | 10 % | | Gel: Estradiolum 1 mg | Orion Pharma AG | B / SL | FB | | G |  |
| | IP | CI | | Divigel 1,0 g | 91 x 1 g | 17.59 | 35.55 | 10 % | | Gel: Estradiolum 1 mg | Orion Pharma AG | B / SL | FB | | G |  |
| | IP | CI | | Oestrogel | 80 g | 7.88 | 17.80 | 10 % | | Gel: Estradiolum | Vifor (International) AG | B / SL | FB | | G |  |
| | IP | CI | | Oestrogel | 80 g | 7.88 | 17.80 | 10 % | | Gel: Estradiolum | Vifor (International) AG | B / SL | FB | | G |  |
| | IP | CI | | Oestrogel | 3 x 80 g | 20.09 | 38.25 | 10 % | | Gel: Estradiolum | Vifor (International) AG | B / SL | FB | | G |  |
| | IP | CI | | Progynova mite | 3 x 28 Dragée(s) | 9.18 | 26.40 | 10 % | | Dragées: Estradioli Valeras 1 mg | Bayer (Schweiz) AG | B / SL | FB | | G |  |
| | IP | CI | | Progynova | 28 | 4.79 | 14.45 | 10 % | | Dragées: Estradioli Valeras 2 mg | Bayer (Schweiz) AG | B / SL | FB | | G |  |
| | IP | CI | | Progynova | 3 x 28 | 11.69 | 29.15 | 10 % | | Dragées: Estradioli Valeras 2 mg | Bayer (Schweiz) AG | B / SL | FB | | G |  |
| | IP | CI | | Estrofem 1 mg N | 28 Tablet(s) | 3.57 | 13.10 | 10 % | | Coated tablets: Estradiolum 1 mg | Novo Nordisk Pharma AG | B / SL | FB | | G |  |
| | IP | CI | | Estrofem 2 mg N | 28 Tablet(s) | 4.22 | 13.80 | 10 % | | Coated tablets: Estradiolum 2 mg | Novo Nordisk Pharma AG | B / SL | FB | | G |  |
| | IP | CI | | Femoston mono | 28 Tablet(s) | 4.17 | 13.75 | 10 % | | Coated tablets: Estradiolum 2 mg | Viatris Pharma GmbH | B / SL | FB | | G |  |
| | IP | CI | | Vagifem 10 µg | 24 Tablet(s) | 20.73 | 40.25 | k.A. | | Vaginal tablets: Estradiolum 10 µg | Novo Nordisk Pharma AG | B | FB | | G |  |
| | IP | CI | | Lenzetto | Flasche(n) à 8.1 ml | 17.68 | 36.80 | k.A. | | transdermales Spray: Estradiolum 1.53 mg | Gedeon Richter (Schweiz) AG | B | FB | | G |  |
| | IP | CI | | Cerina | 4 plaster(s) | 14.38 | 31.25 | 10 % | | Transdermal System: 2 Active Agents | AHP (Schweiz) AG | B / SL | FB | | G |  |
| | IP | CI | | Cerina | 12 plaster(s) | 37.18 | 60.15 | 10 % | | Transdermal System: 2 Active Agents | AHP (Schweiz) AG | B / SL | FB | | G |  |
| | IP | | | Oestradiol Streuli 1 mg/mL | 10 ampoule(s) | PR | PR | k.A. | | Injection solution: Estradioli Dipropionas 1 mg | G. Streuli & Co. AG | B | FB | | G |  |
| | IP | | | Oestradiol Streuli 5 mg/mL | 10 ampoule(s) | PR | PR | k.A. | | Injection solution: Estradioli Dipropionas 5 mg | G. Streuli & Co. AG | B | FB | | G |  |
| | IP | | | Oestradiol K Streuli | 10 ampoule(s) | PR | PR | k.A. | | Injection suspension: 2 Active Agents | G. Streuli & Co. AG | B | FB | | G |  |
| | | | | Oesclim 25 | 8 Systeme | PR | 25.90 | k.A. | | Transdermal System: 2 Active Agents | RCC Registration and Consulting | B | FB | | G |  |
| | | | | Oesclim 37 | 8 Systeme | PR | 25.90 | k.A. | | Transdermal System: 2 Active Agents | RCC Registration and Consulting | B | FB | | G |  |
| | | | | Oesclim 50 | 8 Systeme | PR | 25.90 | k.A. | | Transdermal System: 2 Active Agents | RCC Registration and Consulting | B | FB | | G |  |
| | | | | Oesclim 75 | 8 Systeme | PR | 25.90 | k.A. | | Transdermal System: 2 Active Agents | RCC Registration and Consulting | B | FB | | G |  |
| | | | | Oesclim 100 | 8 Systeme | PR | 25.90 | k.A. | | Transdermal System: 2 Active Agents | RCC Registration and Consulting | B | FB | | G |  |
| | | | | Oesclim 25 | 24 Systeme | PR | 51.90 | k.A. | | Transdermal System: 2 Active Agents | RCC Registration and Consulting | B | FB | | G |  |
| | | | | Oesclim 37 | 24 Systeme | PR | 51.90 | k.A. | | Transdermal System: 2 Active Agents | RCC Registration and Consulting | B | FB | | G |  |
| | | | | Oesclim 50 | 24 Systeme | PR | 51.90 | k.A. | | Transdermal System: 2 Active Agents | RCC Registration and Consulting | B | FB | | G |  |
| | | | | Oesclim 75 | 24 Systeme | PR | 51.90 | k.A. | | Transdermal System: 2 Active Agents | RCC Registration and Consulting | B | FB | | G |  |
| | | | | Oesclim 100 | 24 Systeme | PR | 51.90 | k.A. | | Transdermal System: 2 Active Agents | RCC Registration and Consulting | B | FB | | G |  |
| | IP | CI | | Linoladiol Emulsion ad us. ext. | 25 g | PR | 13.50 | k.A. | | Emulsion: 3 Active Agents | Teva Pharma AG | B | FB | | G |  |
| | | | | Divigel cyclo | Kombipackung(en) | PR | PR | k.A. | | Cream + Vaginal tablets: 3 Active Agents | Orion Pharma AG | B | FB | | G |  |